Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brachytherapy Services, Inc. (BSI) is a medical technology company specializing in the development and manufacture of brachytherapy products for cancer treatment. Based in Chatsworth, California, the company was originally a division of North American Scientific (NAS Medical) before being acquired by Best Medical International (TeamBest) in 2009. BSI's core product line includes the Prospera brand of Iodine-125 and Palladium-103 radioactive seeds, which are used to deliver precise, localized radiation therapy for prostate, breast, and gynecological cancers. In addition to radioactive sources, the company provides specialized delivery systems such as the STP 110 Precision Stepper and various accessories to enhance the accuracy and efficiency of brachytherapy procedures. As part of the TeamBest Global family of companies, BSI continues to support the oncology community with reliable, high-quality solutions for internal radiation therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brachytherapy Services.